Nuvasive Inc., RTI Surgical Inc. and K2M, Inc. are Dominating The Market For Global XLIF Surgery Market In 2016

Global XLIF Surgery Market is expected to reach USD 2,557.74 million by 2024 from USD 1,644.68 million in 2016, at a CAGR of 5.7% in the forecast period 2017 to 2024.  The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Access Full Report: http://databridgemarketresearch.com/reports/global-xlif-surgery-market/

The global fetal monitoring market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. NuVasive Inc. is going to dominate the global XLIF surgery market following with, RTI Surgical Inc. and K2M, Inc.  Other players in this market include Spine Wave, Inc., Tyber Medical LLC., K2M, Inc., Johnson & Johnson Services Inc.,  Titan Spine, DIO MEDICAL, OsteoMed, ZIMMER BIOMET among others holds 26.6% of the global fetal monitoring market in 2016.

NUVASIVE INC.:

Incorporated in 1997 and headquartered at San Diego, California, United States. The company is medical device company in the global spine surgery market. It develops minimally-disruptive surgical products and procedurally-integrated solutions for spine surgery. Its wide range of products is focused on various applications of spine fusion surgery and spinal fusion process.

NuVasive Inc. operates its business through one segment. It reports in two product lines namely, spinal hardware and surgical support.

RTI Surgical Inc.:

Founded in 1997 and headquartered at Alachua, Florida, U.S., RTI Surgicals, Inc., is engaged in the development and marketing of biologic, metal, and synthetic implants. The company operates through four business segments, namely, spine, sports medicine and orthopedics, surgical specialties and cardiothoracic.

The spine product category of the company offers various products pertaining to cervical, lateral, orthobiologics and thoracolumbar. It offers the products Fusion Lateral Disc Prep Set, Lat-Fuse Lateral Plate System, MIS Fusion Instrument Set, Clarity Retractor System and many others.

K2M, INC.:

Founded in 2004 and headquartered at Virginia, United States. K2M is engaged in the development, design and commercialization of the spine and minimally invasive spine technologies and techniques for the treatment of the spinal pathologies. K2M operates in four product categories such as complex spine, minimally invasive, degenerative, and biologics. The portfolio enables the surgeons to efficiently treat the complicated spinal disorders. Minimally invasive product categories offer the lateral interbody fusion systems for the treatment of the wide range of the spinal difficulties. K2M has global presence as their employees serve clinicians and patients in North America, Germany, Ireland, United Kingdom, Austria and Switzerland. The company’s subsidiaries include and others.

Recent Development:

  1. In July 2017, K2M Group Holdings, Inc. signed the agreement with Mitsubishi Corporation subsidiary Japan Medicalnext Co., Ltd. for the distribution of K2M's innovative spinal technologies in Japan.
  2. In October 2016, K2M Group Holdings, Inc. received 510(k) clearance from FDA for the expansion of the CASCADIA Lateral Interbody System, which consists of the Lamellar 3D Titanium Technology. The CASCADIA Lateral Interbody System expanded the portfolio of the company for the minimally invasive surgery products